The present invention relates to the use ofpolyunsaturated fatty acids andone or more components which have a beneficial effect on total methionine metabolism selected from the group consisting of vitamin B12 and precursors thereof, vitamin B6 and derivatives thereof, folic acid, zinc and magnesium,and, preferably, nucleotides,for reducing the severity of ADHD.